The challenge:
Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker testing in a particular tumour
and determine the appropriate stakeholders who are involved in the biomarker evaluation process.
http://www.researchpartnership.com/news/2016/06/case-study-oncology-diagnostic-biomarker-landscaping...